HOME >> BIOLOGY >> NEWS
HPV testing could be future strategy for primary screening for cervical cancer

Authors of a UK study in this week's issue of THE LANCET propose a new approach for cervical cancer screening. Testing for the human papilloma virus (HPV)-the main cause of cervical cancer-could be the primary screening tool, with cytology reserved for women who test positive for HPV.

HPV testing (by genetic analysis) of cervical smears is known to be more sensitive than conventional cytology for detecting pre-malignant cervical cells called high-grade cervical intraepithelial neoplasia (CIN2/CIN3); however HPV testing is less specific than cytology (ie. it produces more 'false-positive' results). HPV testing as a primary screening approach is only feasible if appropriate management is given to women who are HPV-positive with negative or borderline cytology results.

The HART (HPV in Addition to Routine Testing) study was led by Jack Cuzick and colleagues from Cancer Research UK. Around 11,000 women aged 30-60 years from 161 GP practices in 5 UK regions participated in the study between 1998 and 2001. Women with borderline cytology and women positive for high-risk HPV with negative cytology were randomised to immediate colposcopy (detailed examination of the cervix) or to surveillance by repeat HPV testing, cytology, and colposcopy at 12 months.

HPV testing was more sensitive than borderline or worse cytology (97% compared with 77%) but slightly less specific (93% compared with 96%) for detecting malignant cells. Surveillance at 12 months was as effective as immediate colposcopy for women with minimal abnormalities, i.e., those women with either borderline cytology results (regardless of HPV status) or who were HPV positive but had negative cytology results.

Jack Cuzick comments: "HPV testing could be used for primary screening in women older than 30 years, with cytology used to triage HPV-positive women. HPV-positive women with normal or borderline cytology (about 6% of screened women) could be managed by repeat testing after 12 mon
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
4-Dec-2003


Page: 1 2

Related biology news :

1. Far more men than women favor routine paternity testing at birth
2. Nucleic acid-amplification testing further safeguards nations blood supply
3. Clinical judgement still counts strongly alongside genetic testing
4. Genetic testing of embryos to pick savior sibling OK with most Americans
5. Annual bioethics forum to explore genetic testing
6. New toxicity test could cut animal testing
7. Revised guidelines published for testing for hereditary type of colorectal cancer
8. Study calls for end to age thresholds for prenatal genetic testing
9. Genetic testing of embryos
10. High-risk women welcome genetic testing for breast cancer gene
11. Biomedical scientist testing nanoparticles as early cancer detection agent

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2020)... ... 06, 2020 , ... Kerafast Inc. , developers of ... announced an agreement with The Good Food Institute , a nonprofit organization ... partnership, terrestrial meat and aquatic cell lines will be made available to scientists ...
(Date:2/1/2020)... ... February 01, 2020 , ... Liver cancer, called hepatocellular carcinoma (HCC), occurs each ... the disease. HCC is the 5th most common cancer and the 2nd leading cause ... comes to incidence of HCC, while China has half of all patients suffering from ...
(Date:1/29/2020)... ... January 29, 2020 , ... INDIGO Biosciences, Inc. (INDIGO), the ... announced a record earnings year for 2019. With final numbers to be released ... percent increase in revenue and a thirty percent increase in gross profit, and ...
Breaking Biology News(10 mins):
(Date:2/5/2020)... ... , ... Rare Disease Day® , held the last day in February ... (NORD), to raise awareness amongst the general public and decision-makers about rare diseases and ... Mystery” rare disease series will be shining the light on Rare Disease ...
(Date:1/28/2020)... (PRWEB) , ... January 28, 2020 , ... ... Better Salivary Assay Kits . The new Salivary Total Human IgG ... “By measuring total immunoglobulin G in saliva, researchers can extend the accuracy and ...
(Date:1/24/2020)... ... January 24, 2020 , ... Sierra Instruments, ... flow meters and controllers ideal for BioPharm OEMS. Sierra also announces ... rotameters. These thermal instruments employ high-precision MEMS (Micro-Electro Mechanical Systems) technology utilizing an ...
(Date:1/22/2020)... Conn. (PRWEB) , ... January 21, 2020 , ... ... (CTC) liquid biopsy from a simple blood draw, today announced the sale of the ... Health. The Rare Scope will be used in clinical cancer research. , “The RareScope ...
Breaking Biology Technology:
Cached News: